AGER and polycystic ovary syndrome: Considering that the proinflammatory action of AGEs can be neutralized with a sufficiently high concentration of the soluble form of the receptor for AGEs (sRAGE), sRAGE could represent another biomarker and a potential therapeutic target for ovarian dysfunction in PCOS [121].